“…Besides, the advantage of AT-MSCs cells over BM-MSCs is the possibility to harvest them in a less invasive manner [ 31 , 34 ]. However, type 2 diabetic patients suffer from insulin resistance and chronic hyperglycemia, from which AT-MSCs’ functions were impaired in osteogenic differentiation potential and wound healing ability [ 27 , 29 , 35 ]. In previous report, we also demonstrated that the expressions of insulin resistance-related genes PTEN, EGR-1, GGPS-1 in healthy human AT-MSCs-treated with high d -glucose concentrations at 25 mM, 50 mM, and 100 mM were accelerated in comparison with those of human diabetic-derived AT-MSCs [ 27 ].…”